Dynamics of skin barrier repair following topical applications of miconazole nitrate. 2006

E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
Department of Dermatopathology, University Hospital of Liège, Liège, Belgium.

The skin barrier function (SBF) is an important aspect of skin biology, particularly in the elicitation of inflammation. The SBF recovery rate after tape stripping and surfactant challenge can be assessed by measuring the transepidermal water loss (TEWL). Previous clinical studies have shown some inflammatory effect after topical applications of miconazole. The aim of this study was to compare the effect of pastes (petrolatum and 15% zinc oxide) containing or not miconazole nitrate on controlled impaired SBF. Fifteen volunteers were enrolled. In each subject, successive cyanoacrylate skin surface strippings were harvested from 5 sites of the volar forearm until TEWL raised above 15 g/cm(2)/h on all test sites. In addition, one daily soak session with a 0.2% dishwashing liquid further damaged the SBF. Each of the test formulations was applied twice daily for 5 days at two dosages, namely 1 and 2 mg/cm(2), on randomized test sites. Another site remained untreated. TEWL was measured daily for 5 days. A fastened SBF repair was observed on all treated sites, particularly where the largest amount of the products had been applied. A faster SBF recovery rate was obtained at the site receiving the miconazole nitrate paste. We conclude that the occlusive effect of a paste helped mitigate SBF defect. The adjunction of miconazole nitrate improved the efficacy.

UI MeSH Term Description Entries
D008825 Miconazole An imidazole antifungal agent that is used topically and by intravenous infusion. Brentan,Dactarin,Miconasil Nitrate,Miconazole Nitrate,Monistat,R-14,889,Nitrate, Miconasil,Nitrate, Miconazole,R 14,889,R14,889
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001834 Body Water Fluids composed mainly of water found within the body. Water, Body
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
April 1979, Indian journal of dermatology,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
July 1972, Arzneimittel-Forschung,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
June 2012, Expert opinion on pharmacotherapy,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
July 2022, Pakistan journal of pharmaceutical sciences,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
December 1983, American journal of obstetrics and gynecology,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
November 2012, Genome biology,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
January 2009, AAPS PharmSciTech,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
February 2006, Cutis,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
January 2005, Profiles of drug substances, excipients, and related methodology,
E Xhauflaire-Uhoda, and V Vroome, and G Cauwenbergh, and G E Piérard
March 1977, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!